Latest Anti-obesity medication Stories
A recent study by researchers at the Beth Israel Deaconess Medical Center (BIDMC), published in the July 3 issue of Cell Metabolism, has identified the link between metabolic disease and cancer. Senior author Barbara Kahn, MD, a scientist at BIDMC and Professor of Medicine at Harvard Medical School, stated that “Maintaining normal body weight requires tight control of energy homeostasis, which necessitates a constant flow of metabolic input to the hypothalamus in the form of nutrients...
On June 27th, 2012, the US FDA approved the new diet pill Belviq. Belviq (lorcaserin), by Arena Pharmaceuticals, is the first weight-loss drug to be approved in 13 years, according to Reuters. In the briefing documents for the May 10th, 2012 FDA Endocrinologic and Metabolic Drugs Advisory Committee, reviewers expressed concerns on safety of Lorcaserin related mainly to heart problems. Another obesity drug, the popular Fen Phen, was withdrawn from the market in 1997; it was linked with...
hCGTreatments announces a new prescription diet pill that eliminates hunger without side effects, for faster results than the new diet pill, Belvig recently approved by the FDA. Kansas City, MO (PRWEB) July 04, 2012 hCG Treatments / Diet Doc Weight Loss created a new diet pill that eliminates hunger and forces the body to burn fat more efficiently for rapid weight loss results of up to a pound a day, with an average of 15 -25 pounds a month. Whereas the FDA approved new diet pill Belvig...
hCGTreatments announces a prescription diet pill that eliminates hunger altogether without side effects, as compared to the new Diet Pill, Belvig recently approved by the FDA. Phoenix, AZ (PRWEB) July 03, 2012 hCGTreatments / Diet Doc Weight Loss created a new diet pill that eliminates hunger and forces the body to burn more efficiently for fast weight loss averaging up to a pound a day, whereas the newly FDA approved diet pill Belvig is coming up with much less impressive results....
As a diet and supplement authority, Weight Loss Guide has helped tens of thousands of people lose weight and meet their weight loss goals. Its extensive knowledge on the subject matter has led it to formulate a list of the top ways to ruin your weight loss diet. (PRWEB) June 28, 2012 With thousands of weight loss programs and diet pills on the market, it is no wonder people are often confused about the best ways to lose weight. Oftentimes, individuals make small mistakes that end up...
Connie K. Ho for redOrbit.com 78 million. This is the number of people who are obese in the United States, according to the U.S. Center for Disease Control and Prevention (CDC). Obesity increases the risk of diabetes, heart attacks, and strokes. It also costs the U.S. economy $147 billion a year in expenses and lost productivity. With these dire facts in mind, the Food and Drug Administration (FDA) recently approved the anti-obesity prescription drug Belviq from Arena Pharmaceuticals to be...
WASHINGTON, June 27, 2012 /PRNewswire-USNewswire/ -- Today, members of the Obesity Care Continuum (OCC) applauded the Food and Drug Administration's (FDA) approval of a new obesity drug - Belviq (lorcaserin HCl). Belviq is the first obesity drug to be approved in the past 13 years. "This is a tremendous step forward in addressing our most pressing health problem. Healthcare professionals now have a new option to help their patients affected by obesity manage this chronic condition....
An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston. "This new medication is promising because of the amount of weight loss it produces, the resultant improvement in important risk factors for diabetes, and, particularly in the lower dose studied, in its tolerability," said study lead author Donna H. Ryan, M.D.,...
Surprising finding about WNT signaling points to Sfrp5 as a potential target for anti-obesity drugs As the world fights obesity at the human level, scientists at the University of Michigan and their colleagues have made a surprising finding at the microscopic level that could help fuel that fight. Their work helps explain why fat-storing cells get fatter, and burn fat slower, as obesity sets in. If their findings from mice can be shown to apply to humans, they may provide a new target...
On June 27th, 2012, the US FDA is set to decide on new obesity drug Lorcaserin. In the briefing documents for the May 10th, 2012 meeting of the FDA Endocrinologic and Metabolic Drugs Advisory Committee, reviewers expressed concerns on safety of Lorcaserin related mainly to heart problems. The FDA originally declined to approve the drug in 2010 because of concerns including potential effects on patients' hearts. Another obesity drug, the popular Fen Phen, was withdrawn from the market...
